REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sphere Power Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Securities, Commodity Contracts, and Other Financial Investments and Related Activities
Full name: Sphere Power Inc. Profile Updated: July 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

prostemics is a bio enterprise specializing in the production of medical cosmetics with high concentration stem cell cultivation fluids. They have developed a technology for producing exosome cultivation separation tablets and have registered the stem cell exosome series with the U.S. Food and Drug Administration.

Headquarters
22, Apgujeong-Ro 14-Gil, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the Sphere Power Inc. report to view the information.

Website: http://www.prostemics.com

Basic Information
Total Employees:
Purchase the Sphere Power Inc. report to view the information.
Outstanding Shares:
Purchase the Sphere Power Inc. report to view the information.
Registered Capital:
Purchase the Sphere Power Inc. report to view the information.
Financial Auditors:
Purchase the Sphere Power Inc. report to view the information.
Incorporation Date:
June 25, 2014
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
30.1%
Purchase this report to view the information.
5.1%
Purchase this report to view the information.
4.2%
Subsidiaries
(주)더마베이비
(주)리더스솔루션
(주)리더스코스메틱
Company Performance
Financial values in the chart are available after Sphere Power Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
40.18%▲
Total operating revenue
41.38%▲
Operating profit (EBIT)
19.44%▲
EBITDA
39.17%▲
Net Profit (Loss) for the Period
-338.23%▼
Total assets
49.94%▲
Total equity
209.69%▲
Operating Profit Margin (ROS)
17%▲
Net Profit Margin
-44.49%▼
Return on Equity (ROE)
-23.48%▼
Debt to Equity Ratio
-168.37%▼
Quick Ratio
0.67%▲
Cash Ratio
0.11%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo